Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Bristol

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|November 1, 1983
C4-substituted 1-beta-D-ribofuranosylpyrazolo[3,4-d]pyrimidines as adenosine agonist analoguesH W Hamilton, J A Bristol
Henry Ford Hospital Medical Journal|January 1, 1986
New positive inotropic agentsS M Jafri, J A Bristol
Trends in Endocrinology and Metabolism: TEM|December 1, 1994
Regulation of phospholipase C-beta isozymes by G-proteinsJ A Bristol, S G Rhee
Medicinal Research Reviews|July 1, 1983
Agents for the treatment of heart failureJ A Bristol, D B Evans
Cellular Immunology|June 8, 1999
Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transferJ A Bristol, J Schlom, S I Abrams
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 1998
Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic propertiesJ A Bristol, J Schlom, S I Abrams
The Journal of Biological Chemistry|April 5, 1993
Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage siteJ A Bristol, B C Furie, B Furie
Journal of Medicinal Chemistry|May 1, 1985
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivityR E Weishaar, M H Cain, J A Bristol
Life Sciences|November 29, 1982
Adenosine receptors mediating cardiac depressionD B Evans, J A Schenden, J A Bristol
Journal of Medicinal Chemistry|December 1, 1978
Antiallergic activity of some 9H-xanthen-9-one-2-carboxylic acidsJ A Bristol, R Alekel, J Y Fukunaga, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|November 1, 1983
C4-substituted 1-beta-D-ribofuranosylpyrazolo[3,4-d]pyrimidines as adenosine agonist analoguesH W Hamilton, J A Bristol
Henry Ford Hospital Medical Journal|January 1, 1986
New positive inotropic agentsS M Jafri, J A Bristol
Trends in Endocrinology and Metabolism: TEM|December 1, 1994
Regulation of phospholipase C-beta isozymes by G-proteinsJ A Bristol, S G Rhee
Medicinal Research Reviews|July 1, 1983
Agents for the treatment of heart failureJ A Bristol, D B Evans
Cellular Immunology|June 8, 1999
Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transferJ A Bristol, J Schlom, S I Abrams
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 1998
Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic propertiesJ A Bristol, J Schlom, S I Abrams
The Journal of Biological Chemistry|April 5, 1993
Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage siteJ A Bristol, B C Furie, B Furie
Journal of Medicinal Chemistry|May 1, 1985
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivityR E Weishaar, M H Cain, J A Bristol
Life Sciences|November 29, 1982
Adenosine receptors mediating cardiac depressionD B Evans, J A Schenden, J A Bristol
Journal of Medicinal Chemistry|December 1, 1978
Antiallergic activity of some 9H-xanthen-9-one-2-carboxylic acidsJ A Bristol, R Alekel, J Y Fukunaga, et al.
Pageof 4